Paul Smith

Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma

John Radford, Tim Illidge, Nicholas Counsell et al. · New England Journal of Medicine · 2015 · 750 citations · Full text

Medicine, Oncology, Radiology +16

Myocardial Infarction Mortality Risk After Treatment for Hodgkin Disease: A Collaborative British Cohort Study

Anthony J. Swerdlow, Craig Higgins, Paul Smith et al. · JNCI Journal of the National Cancer Institute · 2007 · 448 citations

Medicine, Geriatric Medicine, Chemotherapy +12

Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial

Kirit M. Ardeshna, Wendi Qian, Paul Smith et al. · The Lancet Oncology · 2014 · 388 citations

Medicine, Oncology, Pharmacotherapy +8

Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trial

Lisa Lowry, Paul Smith, Wendi Qian et al. · Radiotherapy and Oncology · 2011 · 386 citations

Medicine, Oncology, Radiation Oncology +12

Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma

Sally F. Barrington, Wendi Qian, Edward J. Somer et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2010 · 341 citations

Medicine, Oncology, Tumor Pathology +9